.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Fish and Richardson
Baxter
Teva
UBS
Healthtrust
Harvard Business School
Julphar
Novartis

Generated: December 14, 2017

DrugPatentWatch Database Preview

Imipramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for imipramine hydrochloride and what is the scope of imipramine hydrochloride patent protection?

Imipramine hydrochloride
is the generic ingredient in five branded drugs marketed by Novartis, Leading Pharma Llc, Lederle, Lupin Ltd, Mallinckrodt Inc, Oxford Pharms, Par Pharm, Roxane, Sandoz, Sun Pharm Industries, Teva, Usl Pharma, Vangard, Watson Labs, West Ward, Abbott, Alra, and Sanofi Aventis Us, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for imipramine hydrochloride. Twenty suppliers are listed for this compound.

Pharmacology for imipramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt IncIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL087846-002May 22, 1984ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL088292-001Oct 21, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL089422-001Jul 14, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL083729-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AlraPRAMINEimipramine hydrochlorideTABLET;ORAL083827-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mallinckrodt IncIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL087846-003May 22, 1984ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL083729-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL089497-001Jul 14, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL083729-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsIMIPRAMINE HYDROCHLORIDEimipramine hydrochlorideTABLET;ORAL085221-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Dow
McKinsey
Novartis
Chinese Patent Office
Queensland Health
Julphar
Daiichi Sankyo
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot